1. 588: ANTI-FACTOR XA TESTING FOR QUANTIFYING ANTICOAGULANT EFFECT DUE TO ORAL DIRECT XA INHIBITORS. Issue 12 (December 2015) Authors: Beyer, Jacob; Trujillo, Toby; Kiser, Tyree Journal: Critical care medicine Issue: Volume 43:Issue 12(2015)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of clinical outcomes using activated partial thromboplastin time versus antifactor-Xa for monitoring therapeutic unfractionated heparin: A systematic review and meta-analysis. Issue 208 (December 2021) Authors: Swayngim, Rebecca; Preslaski, Candice; Burlew, Clay Cothren; Beyer, Jacob Journal: Thrombosis research Issue: Issue 208(2021) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of a Heparin-Calibrated Antifactor Xa Assay for Measuring the Anticoagulant Effect of Oral Direct Xa Inhibitors. (July 2016) Authors: Beyer, Jacob; Trujillo, Toby; Fisher, Sheila; Ko, Ann; Lind, Stuart E.; Kiser, Tyree H. Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 22:Number 5(2016) Page Start: 423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Student Preparation for PGY1 Residency Training by US Colleges of Pharmacy: Survey of the Residency Program Director Perspective. Issue 2 (February 2017) Authors: Mutz, Alyssa B.; Beyer, Jacob; Dickson, Whitney L.; Gutman, Irina; Yucebay, Filiz; Lepkowsky, Marcie; Chan, Juliana; Carter, Kristen; Shaffer, Christopher L.; Fuller, Patrick D. Journal: Hospital pharmacy Issue: Volume 52:Issue 2(2017) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗